Fingerprint
Dive into the research topics of 'The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: Long-term follow-up'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ravin J. Garg, Hagop Kantarjian, Susan O'Brien, Alfonso Quintás-Cardama, Stefan Faderl, Zeev Estrov, Jorge Cortes
Research output: Contribution to journal › Article › peer-review